10-K Decoder · All companies

Xenon Pharmaceuticals Inc.

XENE · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$7.50M$0K
Operating income−$373M−$279M−33.6%
Net income−$346M−$234M−47.6%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$120M−$96.3M−24.7%
Net income−$110M−$90.9M−21.5%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Xenon Pharmaceuticals's revenue in FY2025?
$7.50M in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Feb 2026.
Was Xenon Pharmaceuticals profitable in FY2025?
No: net income was −$346M and operating income −$373M in FY2025.
What was Xenon Pharmaceuticals's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Nov 9, 2026.